Nobel laureate letter opposing RFK Jr confirmation loaded with Dem donors, officials: ‘Thinly veiled attempt’

A group of 77 Nobel laureates recently penned an open letter urging against the confirmation of Robert F. Kennedy Jr. as the Department of Health and Human Services (HHS) Secretary nominee. The letter argues that placing Kennedy in charge of DHHS would jeopardize public health and undermine America’s global leadership in health sciences. However, a closer look at the signatories reveals that many of them are political donors, with a majority supporting Democratic campaigns.

Among the signatories are individuals like Steven Chu, former President Barack Obama’s secretary of Energy, who donated to Hillary Clinton’s presidential campaign in 2016. Nobel Medicine Laureate Joseph L. Goldstein has also contributed to various Democratic campaigns, including those of former Rep. Beto O’Rourke and former President Joe Biden. Additionally, George A. Akerlof, an American economist married to Treasury Secretary Janet Yellen, has donated to Biden and the DCCC, among others.

The letter signed by these Nobel laureates echoes similar sentiments expressed in previous letters warning against the economic dangers of re-electing President Donald Trump. Many of the signatories have supported Biden and Democratic initiatives, such as Build Back Better. While some signatories, like chemist Louis E. Brus, have donated to Democratic campaigns, others have supported figures like Rep. Alexandria Ocasio-Cortez, former Vice President Kamala Harris, and Sen. Elizabeth Warren.

Despite the opposition to Kennedy’s confirmation, he has garnered support from the medical community, including IMA Action, a coalition of over 15,000 healthcare professionals. This coalition is actively advocating for Kennedy’s confirmation and pushing back against what they perceive as “falsehoods” propagated by Pharma-financed opposition to Kennedy.

Kennedy’s confirmation hearing is scheduled for Wednesday at 10 a.m. Despite facing opposition and support from various factions, Kennedy’s nomination remains a contentious issue. It is clear that his confirmation would have far-reaching implications for America’s healthcare system and public health initiatives.

In conclusion, the debate surrounding Kennedy’s confirmation underscores the complex intersection of politics, healthcare, and public health. As the confirmation process unfolds, it is crucial for stakeholders to critically evaluate the arguments presented and consider the broader implications for the nation’s healthcare system.